文献速递肝病消化道肿瘤与早癌

功能性哺乳动物雷帕霉素靶蛋白复合物1信号对c-Myc驱动的肝癌发生不可或缺

A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.
PubMed 文献 · Hepatology · 2017-05-22

该研究在小鼠模型中证实,mTORC1通路被激活且为c-Myc依赖性肝癌发生所必需;敲除Raptor可强烈抑制c-Myc肝脏肿瘤形成,mTORC1下游的S6K/S6与4E-BP1/eIF4E信号级联亦为必需;c-Myc肿瘤细胞中氨基酸转运体SLC1A5和SLC7A6上调,促进包括谷氨酰胺在内的氨基酸摄取,而氨基酸对mTORC1激活至关重要;在人类肝细胞癌标本中,c-Myc水平与mTORC1激活及SLC1A5、SLC7A6水平直接相关。

要点

  • 敲除mTORC1特有成员Raptor可强烈抑制c-Myc肝脏肿瘤形成。
  • mTORC1下游S6K/S6与4E-BP1/eIF4E信号级联为c-Myc驱动肿瘤发生所必需。
  • c-Myc肿瘤细胞中SLC1A5和SLC7A6上调,氨基酸摄取增强,抑制氨基酸可抑制mTORC1。

核心结论

  • 完整的mTORC1轴为c-Myc驱动的肝癌发生所必需;靶向mTOR通路或氨基酸转运体可能成为治疗c-Myc信号激活的肝细胞癌的有效且新颖的治疗选择。

研究设计与样本

  • 研究采用小鼠模型及人类肝细胞癌标本,探讨mTORC1通路在c-Myc驱动肝癌发生中的作用。

主要发现

  • 敲除Raptor强烈抑制c-Myc肝脏肿瘤形成。
  • mTORC1下游的p70核糖体S6激酶/核糖体蛋白S6和真核翻译起始因子4E结合蛋白1/真核翻译起始因子4E信号级联为c-Myc驱动肿瘤发生所必需。
  • 微阵列表达分析显示包括SLC1A5和SLC7A6在内的多种氨基酸转运体上调,导致c-Myc肿瘤细胞对包括谷氨酰胺在内的氨基酸大量摄取。
  • 抑制氨基酸可抑制c-Myc肿瘤细胞中的mTORC1,表明氨基酸对mTORC1激活至关重要。
  • 在人类肝细胞癌标本中,c-Myc水平与mTORC1激活水平以及SLC1A5和SLC7A6水平直接相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Amplification and/or activation of the c-Myc proto-oncogene is one of the leading genetic events along hepatocarcinogenesis. The oncogenic potential of c-Myc has been proven experimentally by the finding that its overexpression in the mouse liver triggers tumor formation. However, the molecular mechanism whereby c-Myc exerts its oncogenic activity in the liver remains poorly understood. Here, we demonstrate that the mammalian target of rapamycin complex 1 (mTORC1) cascade is activated and necessary for c-Myc-dependent hepatocarcinogenesis. Specifically, we found that ablation of Raptor, the unique member of mTORC1, strongly inhibits c-Myc liver tumor formation. Also, the p70 ribosomal S6 kinase/ribosomal protein S6 and eukaryotic translation initiation factor 4E-binding protein 1/eukaryotic translation initiation factor 4E signaling cascades downstream of mTORC1 are required for c-Myc-driven tumorigenesis. Intriguingly, microarray expression analysis revealed up-regulation of multiple amino acid transporters, including solute carrier family 1 member A5 (SLC1A5) and SLC7A6, leading to robust uptake of amino acids, including glutamine, into c-Myc tumor cells. Subsequent functional studies showed that amino acids are critical for activation of mTORC1 as their inhibition suppressed mTORC1 in c-Myc tumor cells. In human hepatocellular carcinoma specimens, levels of c-Myc directly correlate with those of mTORC1 activation as well as of SLC1A5 and SLC7A6. CONCLUSION: Our current study indicates that an intact mTORC1 axis is required for c-Myc-driven hepatocarcinogenesis; thus, targeting the mTOR pathway or amino acid transporters may be an effective and novel therapeutic option for the treatment of hepatocellular carcinoma with activated c-Myc signaling. (Hepatology 2017;66:167-181).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Liu P, Ge M, Hu J, et al. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis. Hepatology. 2017. PMID: 28370287. doi:10.1002/hep.29183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。